Literature DB >> 17703308

Which statin should be used together with colchicine? Clinical experience in three patients with nephrotic syndrome due to AA type amyloidosis.

Garip Sahin1, Cengiz Korkmaz, Ahmet Uğur Yalcin.   

Abstract

Colchicine and statins are well known drugs that cause myopathy and neuropathy. Co-administration of certain drugs with statins may increase myotoxic effect, causing myopathy and varying degrees of rhabdomyolysis. Therefore, it is very crucial to know which statin should be used during a combination therapy including colchicine and other drugs. We present three cases with AA amyloidosis secondary to familial Mediterranean fever, who developed neuromyopathy while receiving the combination of colchicine and statin. We also briefly discussed the different metabolic pathways of statins and colchicine when used together.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703308     DOI: 10.1007/s00296-007-0435-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  11 in total

1.  Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome.

Authors:  R D Toto; S M Grundy; G L Vega
Journal:  Am J Nephrol       Date:  2000 Jan-Feb       Impact factor: 3.754

Review 2.  HMG-CoA reductase inhibitors and myotoxicity.

Authors:  M Ucar; T Mjörndal; R Dahlqvist
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 3.  Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.

Authors:  A J Lee; D S Maddix
Journal:  Ann Pharmacother       Date:  2001-01       Impact factor: 3.154

4.  Colchicine myopathy and neuropathy.

Authors:  R W Kuncl; G Duncan; D Watson; K Alderson; M A Rogawski; M Peper
Journal:  N Engl J Med       Date:  1987-06-18       Impact factor: 91.245

Review 5.  Rhabdomyolysis and HMG-CoA reductase inhibitors.

Authors:  M A Omar; J P Wilson; T S Cox
Journal:  Ann Pharmacother       Date:  2001-09       Impact factor: 3.154

6.  Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients.

Authors:  Cüneyt Ensari; Arzu Ensari; Necmiye Tümer; Ergun Ertug
Journal:  Nephrol Dial Transplant       Date:  2005-06-21       Impact factor: 5.992

7.  Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study.

Authors:  Mehmet Tunca; Servet Akar; Fatos Onen; Huri Ozdogan; Ozgur Kasapcopur; Fatos Yalcinkaya; Ercan Tutar; Seza Ozen; Rezan Topaloglu; Engin Yilmaz; Mustafa Arici; Aysin Bakkaloglu; Nesrin Besbas; Tekin Akpolat; Ayhan Dinc; Eren Erken
Journal:  Medicine (Baltimore)       Date:  2005-01       Impact factor: 1.889

8.  Simvastatin-fluconazole causing rhabdomyolysis.

Authors:  Aasma Shaukat; Mustafa Benekli; Georgirene D Vladutiu; James L Slack; Meir Wetzler; Maria R Baer
Journal:  Ann Pharmacother       Date:  2003 Jul-Aug       Impact factor: 3.154

9.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

10.  Rhabdomyolysis in association with simvastatin and amiodarone.

Authors:  Laurent Roten; Ronald A Schoenenberger; Stephan Krähenbühl; Raymond G Schlienger
Journal:  Ann Pharmacother       Date:  2004-04-06       Impact factor: 3.154

View more
  5 in total

1.  Effect of steady-state atorvastatin on the pharmacokinetics of a single dose of colchicine in healthy adults under fasted conditions.

Authors:  Matthew W Davis; Suman Wason
Journal:  Clin Drug Investig       Date:  2014-04       Impact factor: 2.859

2.  Intima media thickness of carotid arteries in familial Mediterranean fever: a systematic review and meta-analysis.

Authors:  Mira Merashli; Tommaso Bucci; Daniele Pastori; Pasquale Pignatelli; Paul R J Ames
Journal:  Clin Rheumatol       Date:  2022-08-06       Impact factor: 3.650

3.  Colchicine-Induced Acute Neuromyopathy in a Patient Using Concomitant Fluconazole: Case Report and Literature Review.

Authors:  Yi-Chia Su; Chih-Chien Wu
Journal:  Drug Saf Case Rep       Date:  2015-12

4.  Colchicine triggered severe rhabdomyolysis after long-term low-dose simvastatin therapy: a case report.

Authors:  Clara Frydrychowicz; Bastian Pasieka; Matthias Pierer; Wolf Mueller; Sirak Petros; Lorenz Weidhase
Journal:  J Med Case Rep       Date:  2017-01-04

5.  [Colchicine: old medication with new benefits : Use in rheumatology and beyond].

Authors:  Z Boyadzhieva; N Ruffer; M Krusche
Journal:  Z Rheumatol       Date:  2021-06-07       Impact factor: 1.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.